Sat, Jan 31, 2015, 12:36 AM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Boston Scientific Corporation Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • juststent3195 juststent3195 Oct 26, 2006 4:01 PM Flag

    the evening world news

    ARC did what you wanted to happen. No significant difference in LT from Cypher and BMS.

    You state we need to take a step back because of the uncertainty of stenting because of thrombosis (DES and BMS).

    Stents have been used for well over 10-12 years. How much futher back do you want to go.

    I think Taxol is a terrible drug for CAD, and the FDA will analyse it in the ARC terms. Taxus, as a first generation DES, will be shown for the holes you claim eventually. Cypher is much cleaner.

    CABG will always have its place, but continue to dimish in case volume. Patients want less invasive, and you can't blame them.

14.81-0.04(-0.27%)Jan 30 4:07 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Boot Barn Holdings, Inc.
NYSEFri, Jan 30, 2015 4:02 PM EST
Visa Inc.
NYSEFri, Jan 30, 2015 4:00 PM EST